Congenital lactose intolerance is triggered by severe mutations on both alleles of the lactase gene by Lena Diekmann et al.
Diekmann et al. BMC Gastroenterology  (2015) 15:36 
DOI 10.1186/s12876-015-0261-yRESEARCH ARTICLE Open AccessCongenital lactose intolerance is triggered by
severe mutations on both alleles of the lactase
gene
Lena Diekmann, Katrin Pfeiffer and Hassan Y Naim*Abstract
Background: Congenital lactase deficiency (CLD) is a rare severe autosomal recessive disorder, with symptoms like
watery diarrhea, meteorism and malnutrition, which start a few days after birth by the onset of nursing. The most
common rationales identified for this disorder are missense mutations or premature stop codons in the coding
region of the lactase-phlorizin hydrolase (LPH) gene. Recently, two heterozygous mutations, c.4419C > G (p.Y1473X)
in exon 10 and c.5387delA (p.D1796fs) in exon 16, have been identified within the coding region of LPH in a
Japanese infant with CLD.
Methods: Here, we investigate the influence of these mutations on the structure, biosynthesis and function of LPH.
Therefore the mutant genes were transiently expressed in COS-1 cells.
Results: We show that both mutant proteins are mannose-rich glycosylated proteins that are not capable of exiting
the endoplasmic reticulum. These mutant proteins are misfolded and turnover studies show that they are ultimately
degraded. The enzymatic activities of these mutant forms are not detectable, despite the presence of lactase and
phlorizin active sites in the polypeptide backbone of LPH-D1796fs and LPH-Y1473X respectively. Interestingly, wild
type LPH retains its complete enzymatic activity and intracellular transport competence in the presence of the
pathogenic mutants suggesting that heterozygote carriers presumably do not show symptoms related to CLD.
Conclusions: Our study strongly suggests that the onset of severe forms of CLD is elicited by mutations in the LPH
gene that occur in either a compound heterozygous or homozygous pattern of inheritance.
Keywords: Carbohydrate malabsorption, Lactase deficiency, Brush border membrane enzymes, Compound
heterozygote inheritanceBackground
Congenital lactase deficiency (CLD, OMIM 223000) is a
rare and severe autosomal recessive disorder, affecting
newborn infants [1-7]. Symptoms of CLD, like watery diar-
rhea, meteorism and malnutrition, begin a few days after
birth by the onset of nursing. Small intestinal biopsy speci-
mens reveal normal shape of the microvilli, but very low
levels of lactase-phlorizin hydrolase (LPH) [NP_002290],
the enzyme responsible for the digestion of lactose, the
main carbohydrate in mammalian milk [8,9]. The treat-
ment strategy in those cases is the removal of lactose from
the diet, but this has to occur extremely rapidly due to the* Correspondence: hassan.naim@tiho.hannover.de
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unless otherwise stated.life-threatening dehydration and electrolyte loss in the
newborns.
LPH is a type I transmembrane glycoprotein that is com-
posed of 4 homologous protein domains, which reveal 38%
to 55% identity to each other [10]. Due to the high similar-
ity among the four domains, the consensus has emerged
that LPH has arisen from two subsequent gene duplications
[11]. Out of these, only domain III with the phlorizin-
hydrolase activity at position Glu1273 and domain IV with
the lactase activity at Glu1749 are present in mature LPH
[12]. LPH is synthesized as a polypeptide precursor that co-
translationally acquires N-linked glycans in the ER and
forms homodimeric quaternary structure before getting
trafficked to the Golgi apparatus. In addition to N-
glycosylation, LPH is also O-glycosylated. Both types oftral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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tein trafficking and subsequent enzymatic activity. Thus, al-
tered glycosylation can affect the activity as well as the cell
surface exposure of LPH [13,14]. Also, homodimerization
of LPH has been shown to be required for the proper activ-
ity of this protein [15,16].
Appearance of premature stop codons and therefore
truncated protein as a result of frame shifts, missense
mutations in the coding region of LPH or exon duplica-
tion are the most common rationales identified so far
for CLD [3,6,17]. Some other cases include mutations
leading to single amino acid substitutions that can inter-
fere with the proper maturation and function of LPH
[4,5]. Nevertheless, few studies until present have related
the genetics in CLD with the function of the mutations
and their implications in the onset of the disease.
Recently, two heterozygous mutations have been identi-
fied within the coding region of the lactase gene in a
Japanese infant with CLD, both resulting in a truncated
protein [3]. In this study we investigated the two muta-
tions, Y1473X and D1796fs at the biochemical and cellular
levels, by analyzing the biosynthetic and functional features
of mutated LPH and examined their potential influence on
the wild type LPH, mimicking thus the situation in hetero-
zygote carriers of these mutations.
Methods
Materials
Tissue culture dishes were obtained by Sarstedt (Germany).
Dulbecco’s modified Eagle’s medium (DMEM, 1.0 g/L Glu-
cose), minimum essential medium (MEM), chloroquine,
pepstatin, leupeptin, antipain, aprotinin, trypsin-inhibitor,
phenylmethanesulfonyl fluoride, Triton X-100 and Protein-
A Sepharose were purchased from Sigma (Germany).
Trypsin-EDTA, streptomycin, penicillin, glutamine and fetal
calf serum (FCS) were acquired from PAA Laboratories
GmbH (Germany). DEAE-dextran was purchased from
Pharmacia (Germany). Proof reading Isis DNA polymerase
was obtained from MP Biomedicals. Molecular weight
standard for SDS-PAGE was purchased from Thermo
Scientific GmbH (Germany). L-[35S] methionine was ac-
quired from Perkin Elmer. Restriction enzymes were ob-
tained from Thermo Scientific GmbH (Germany). Glucose
oxidase-peroxidase mono-reagent for detection of glucose
was purchased from Axiom (Germany) and endoglycosidase
H was from Roche Diagnostics (Germany). DTT was pur-
chased from Carl Roth GmbH (Germany).
Antibodies
Monoclonal mouse antibodies MLac1, MLac10 [18] and
HBB 1/909 [19] were used against human intestinal LPH.
For immunoprecipitation a mixture of these antibodies
was used to detect all conformations and glycoforms of
LPH, whereas for immunofluorescent studies HBB 1/909was used. The secondary antibody coupled to Alexa Fluor
488 dye was obtained from Invitrogen (Germany).
Generation of complementary DNA clones
LPH was cloned in the vector pSG5 with the Eco RI re-
striction sites of LPH [20]. The mutations were intro-








Oligonucleotides were provided by Sigma (Germany)
and the sequence analysis was performed by GATC
Biotech AG (Germany).
Transient transfection of COS-1 cells, biosynthetic
labeling, immunoprecipitation and enzymatic activity
measurement
COS-1 cells were cultured in humidified atmosphere con-
taining 5% CO2 at 37°C in Dulbecco’s Modified Eagle’s
Medium (DMEM) containing 10% FCS and 5% penicillin
and streptomycin. Cells were seeded at a confluency of
30–40% and then transfected with 5 μg of cDNA encoding
wild type LPH or LPH-Y1473X and LPH-D1796fs by the
diethylaminoethyl-dextran method [20]. Metabolic labeling
was performed with 40 μCi [35S] methionine for 6 h con-
tinuously or in a pulse chase experiment for different time
points in methionine-free MEM medium. Cells lysis and
immunoprecipitation with a mixture of monoclonal anti-
LPH antibodies conjugated to Protein-A-sepharose were
performed as described before [17,19]. The immunoprecip-
itates were either treated with endo H for 90 min at 37°C,
as previously described [21] to examine the glycosylation
pattern or incubated with lactose (28 mmol/ L) for 1 h at
37°C to determine the lactase activity according to Dahlq-
vist using lactose as the substrate [22]. The amount of glu-
cose generated by lactose hydrolysis was assessed by the
Glucose oxidase-peroxidase mono-reagent method. Finally,
the samples were analyzed using a 6% SDS-PAGE accord-
ing to Laemmli (1970) and the protein bands were detected
by a phosphorimaging device and quantified using the
Quantity One® software from Bio Rad Laboratories GmbH
(Germany).
Confocal fluorescence microscopy
Transiently transfected COS-1 cells, expressing the wild
type LPH, LPH-Y1473X and LPH-D1796fs, were grown on
cover slips, fixed with 4% Paraformaldehyde and perme-
abilized with 0.5% Saponin. Immunolabeling was carried
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primary antibody and anti-mouse IgG conjugated with
Alexa 488 (1:500) as the secondary antibody. Confocal laser
microscopy was performed with the Leica TCS SP5 micro-
scope using the x63 oil planachromat lens (Leica Microsys-
tems, Germany).
Results and discussion
Biosynthesis, processing, cellular localization and function
of the mutants LPH-Y1473X and LPH-D1796fs
Until present seven mutations in the coding region of LPH
have been identified in Finnish families. Recent genetic
testing has revealed two novel mutations, Y1473X and
D1796fs, which were found as compound heterozygous
pattern in a Japanese infant with CLD [3]. The genotype/
phenotype relationship is examined in this paper at the
biochemical and cell biological levels. Both mutations are
located in domain IV of the extracellular region of LPH
compatible with partial truncation of homologous domain
IV and complete elimination of the entire membrane an-
chor as well as the cytoplasmic tail.
Since both mutations appeared in a compound hetero-
zygous mode in one patient, we were interested in inves-
tigating the influence of each single mutation per se on
the enzymatic function and intracellular transport events
of LPH.
For this purpose the mutations, Y1473X and D1796fs,
were introduced into the coding region of wild type LPH
separately (thereafter referred to as LPH-Y1473X and
LPH-D1796fs) and the generated mutants were expressed
in COS-1 cells. Detergent extracts of the biosynthetically-
labeled transfected cells were immunoprecipitated.
To assess the differences in maturation state and glycosyla-
tion pattern among wild type LPH, LPH-Y1473X
and LPH-D1796fs, the immunoprecipitates were treated
with endoglycosidase H [21]. Endo H cleaves exclusively
mannose-rich and some hybrid types of N-glycans which
exist in the ER up to cis-Golgi. Figure 1A shows that wild
type LPH revealed a 215 kDa mannose-rich glycosylated,
endo H-sensitive band and a 230 kDa endo H-resistant
complex glycosylated band. By contrast, LPH-Y1473X
and LPH-D1796fs revealed exclusively endo H-sensitive
mannose-rich protein bands respectively smaller than their
untreated forms. We further addressed the trafficking of
the two mutant proteins by performing pulse chase experi-
ments. For this purpose, COS-1 cells were biosynthetically
labeled for 2 h and chased for 0, 4, 8 and 12 h. Figure 1B
shows that wild type LPH reached the status where 50% of
the protein is mannose-rich glycosylated and 50% is com-
plex glycosylated after 4 h of chase. After 12 h of chase,
only the mature form was detectable. The mutated protein
variants, LPH-Y1473X and LPH-D1796fs, persisted as
mannose-rich glycosylated proteins, but remarkably the
bands disappeared almost completely after 8 h of chase. Toexamine the possibility whether the mutants are ultimately
secreted, the media of the biosynthetically labeled COS-
1 cells were collected and immunoprecipitated. How-
ever, neither the wild type LPH nor the two mutated
proteins exhibited any secreted forms (data not
shown). These results indicate clearly that the mutants
persist in their mannose-rich glycosylated forms, likely
in the ER, and are ultimately degraded.
Persistence of the two mutants as mannose-rich glycosyl-
ated species is suggestive of an ER localization of the two
protein variants. To substantiate these results using a dif-
ferent procedure, we analyzed the intracellular localization
of the mutants by confocal immunofluorescence micros-
copy. As shown in Figure 2, wild type LPH is located in the
ER and the Golgi apparatus as well as at the cell surface,
while both mutant variants were predominantly located in
the ER as assessed by the typical ER net-like structures.
The lactase active site is located at Glu1749, while that
of phlorizin-hydrolase at Glu1273 [12]. The mutant
LPH-Y1473X lacks the lactase activity site and it was
therefore expected that this mutant reveals no lactase
activity, which we confirmed. The mutant LPH-D1796fs
contains the lactase active site, but its activity towards
lactose was undetectable (data not shown). These results
indicate that the compound heterozygote pattern of
these two functional-inactive mutants is responsible for
complete lactose intolerance in the infant.
Potential effects of the mutants LPH-Y1473X and LPH-D1796fs
on wild type LPH in a heterozygote background
CLD in the patient was initially suggested by typical mal-
absorption symptoms upon milk uptake and subse-
quently through the identification of the mutations
Y1473X and D1796fs on each allele of the LPH gene.
The compound heterozygote pattern of inheritance
in this CLD case raises questions related to potential
lactose tolerance in the parents, who are heterozygote
carriers of one of the defective LPH alleles. We ad-
dressed therefore the question whether a single normal
parental allele in conjunction with the diseased one is
sufficient to produce lactase protein that has adequate
digestive capacity towards dietary lactose. The rationale for
this assumption is the dimeric quaternary structure of wild
type LPH that is generated in the ER and warrants enzym-
atic activity as well as transport competence of LPH [16].
Provided that minimal folding requirements are fulfilled,
such as correct folding of domains involved in dimerization
of LPH, it should be still considered that two different pro-
tein isoforms, such as a wild type LPH and a truncated
LPH mutant can form heterodimers, which may regulate
the enzymatic function. We mimicked therefore the in vivo
situation by co-expression of each mutant separately with
the wild type LPH, assessed their potential interaction in
co-immunoprecipitation experiments and analyzed the
Figure 1 Biosynthesis and transport kinetics of wild type and mutant proteins. COS-1 cells were transiently transfected with cDNAs
encoding the wild type LPH, LPH-Y1473X or LPH-D1796fs and used 48 h after transfection. A) The cells were metabolically labeled with [35S]
methionine for 6 h continuously, lysed, immunoprecipitated with mAb anti-LPH and treated with endo H. B) The cells were labeled with [35S]
methionine for 2 h and chased for 0, 4, 8 and 12 h, followed by cell lysis and immunoprecipitation. In all these experiments, the proteins were
subjected to SDS-PAGE and autoradiography. The quantification was performed by Quantity One® software.
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protein bands corresponding to wild type LPH that were
obtained by immunoprecipitation of cellular lysates from
co-transfected and biosynthetically-labelled cells. Since nei-
ther the LPH-Y1473X nor LPH-D1796fs mutants appeared
in the same electrophoretic lane we conclude that these
mutant forms did not co-immunoprecipitate or interact
with the wild type LPH.
The enzymatic activities of LPH in the co-transfected
experiments did not change or support the notion thatFigure 2 Intracellular localization of wild type and the mutants in CO
expressing the wild type LPH, LPH-Y1473X or LPH-D1796fs, were fixed with
Immunolabeling was carried out using mAb anti-LPH (1:1000) as the prima
secondary antibody (1:500). The samples were analyzed by confocal laser minteraction has taken place. This in turn clearly indicated
that wild type LPH retained its full activity since it has
generated its enzymatically active homodimers.
Mutant LPH-Y1473X or LPH-D1796fs are not
temperature-sensitive
Several mutations in proteins that are associated with
protein folding diseases exhibit a temperature sensitive
pattern, in which lowering the temperature leads to a re-
covery of correct folding and further protein traffickingS-1 cells. For visualization of LPH, transiently transfected COS-1 cells,
4% paraformaldehyde and permeabilised with 0.5% saponin.
ry antibody and anti-mouse IgG conjugated with Alexa 488 as the
icroscopy.
Figure 3 Potential interaction of LPH-Y1473X and LPH-D1796fs with wild type LPH in co-transfection experiments. COS-1 cells were
transiently transfected either with cDNA encoding wild type LPH tagged with myc (LPH-myc) or cDNA clones encoding the mutants LPH-Y1473X
and LPH-D1796fs. In another set of experiments, coexpression of LPH-myc with LPH-Y1473X or with LPH-D1796fs was performed in COS-1 cells.
48 h posttransfection the cells were metabolically labeled with [35S] methionine for 6 h continuously, lysed and the lysates were immunoprecipitated
with either an antibody against myc to detect wild type LPH or a mixture of mAb anti-LPH antibodies to detect the mutants. Lactase activity was
measured by determining the concentration of glucose generated by lactose hydrolysis by the Glucose oxidase-peroxidase mono-reagent method using
photometric analysis. The total protein amount of each sample was determined by SDS-PAGE and autoradiography to calculate subsequently the relative
specific activity. The quantification was performed by Quantity One® software. The results of LPH-Y1473X were taken from another gel with higher quality.
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temperature-sensitive and can exit the ER to the Golgi
apparatus in a time-delayed manner, a pulse chase ex-
periment was performed at 20°C. The control utilized a
similar protocol except that the temperature was chan-
ged to 37°C. The wild type LPH was detectable as a
mannose-rich glycosylated and a complex glycosylated
protein band after 6 h and 18 h of chase at 20°C incuba-
tion temperature (Figure 4). At this temperature proteins
are predominantly blocked in the Golgi apparatus [26].
This becomes evident in the 18 h chase time point,
which shows substantial increase in the intensity of the
complex glycosylated mature protein that is processed in
the Golgi apparatus. In contrast to the wild type LPH,
both mutant proteins appeared as mannose-rich glyco-
sylated species after 6 h of chase at 20°C and did not
reach a further maturation status after 18 h of chase,
since no complex glycosylated band appeared. The same
experiment was performed at 37°C. Interestingly, wild
type LPH was still detectable after 18 h of chase, mainly
as the mature complex glycosylated form, but LPH-
Y1473X or LPH-D1796fs disappeared completely sug-
gesting that the mutants are subject to a degradation
mechanism in the ER.
Conclusions
The hydrolysis of lactose, the main carbohydrate in
mammalian milk in the intestinal lumen is achieved by
LPH that cleaves the β-glycosidic linkage betweenglucose and galactose and enables the transport of the
liberated monosaccharides across the brush border
membrane of intestinal epithelial cells into the cell in-
terior. The failure to digest a disaccharide to its funda-
mental monosaccharides, for example due to the
absence of the corresponding disaccharidase, results in
carbohydrate malabsorption. One type of carbohydrate
malabsorption is congenital lactase deficiency (CLD), a
rare and severe autosomal recessive gastrointestinal
disorder, initially affecting newborns [1,6]. Typical
symptoms of CLD start from a few days after birth,
consisting of liquid and acidic diarrhea, meteorism
and severe malnutrition. Appearance of premature
stop codons leading to an early truncation of the pro-
tein or missense mutations in the coding region of
LPH are the common causes identified so far for this
disease [1,2,6].
Recently, two novel mutations in the gene of LPH,
leading to an early truncation due to a stop codon and
a frame shift, were found in a compound heterozygous
mode in a Japanese infant with CLD [3]. In this study
we showed that these mutants persist predominantly
as a mannose-rich glycosylated protein in the ER, are
enzymatically inactive and thereby trigger the onset of
CLD. Furthermore, our data suggest no interaction be-
tween these mutants to generate pseudo-heterodimer
complexes that may alter the functional or trafficking
characteristics of either one of them. Heterodimeric
interactions have been described for many proteins
Figure 4 Biosynthesis and glycosylation pattern of wild type LPH, LPH-Y1473X and LPH-D1796fs at 20°C and 37°C. Transiently
transfected COS-1 cells, expressing wild type LPH, LPH-Y1473X or LPH-D1796fs were labeled with [35S] methionine for 3 h and chased for 6 h and
18 h at 20°C (A) and 37°C (B) followed by cell lysis, immunoprecipitation and endo H treatment. The proteins were subjected to SDS-PAGE and
autoradiography. The quantification was performed by Quantity One® software.
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heterodimers, G-protein-coupled receptors or GABA
(B) receptors [27-29]. An interaction between the wild type
LPH and either one of the mutants does not occur and
lead to variations in the enzymatic function of LPH. These
data explain why the parents do not reveal symptoms asso-
ciated with lactose intolerance.
The mutations described in this report are similar to
another nonsense mutation (Y1390X), called Fin
(major), which was detected with 84% occurrence in a
study with 32 Finnish CLD patients [6]. This mutated
protein is also enzymatically inactive and is retained in
the ER.
In conclusion, our study suggests that the onset of
severe osmotic diarrhea due to CLD is elicited by se-
vere mutations in the LPH gene that occur in either a
compound heterozygous or homozygous pattern of in-
heritance. This view is supported by the observations
that a heterozygote wild type LPH retains its complete
activity and intracellular maturation in presence of a
pathogenic LPH mutant as shown in co-expression ex-
periments. Wild type LPH generates normally homodi-
mers that are enzymatically active and transport competent.
Our study suggests that an interaction between a wild type
LPH monomer with a pathogenic LPH mutant apparently
does not exist, otherwise heterodimers with altered function,trafficking and maturation characteristics of LPH would
have been generated. Nevertheless, additional studies are
required with a panel of LPH mutants with variations
in their folding pattern, function and pathogenicities
to determine whether a potential interaction between
these mutants and wild type LPH occurs, which would
be associated with mild to severe forms of CLD.
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